BIOMERICA INC. - COMMON STOCK

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

10 11 2023 08:19:00 提供 Nasdaq GlobeNewswire

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

08 11 2023 08:19:00 提供 Nasdaq GlobeNewswire

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

13 10 2023 13:10:28 提供 Nasdaq GlobeNewswire

Biomerica Reports First Quarter 2024 Financial Results

13 10 2023 06:39:00 提供 Nasdaq GlobeNewswire

Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test

26 9 2023 08:19:00 提供 Nasdaq GlobeNewswire

Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

28 8 2023 08:19:00 提供 Nasdaq GlobeNewswire

Biomerica Reports Fiscal 2023 Year End Results

25 8 2023 17:00:00 提供 Nasdaq GlobeNewswire

CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test

03 8 2023 08:19:00 提供 Nasdaq GlobeNewswire

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

21 6 2023 08:19:00 提供 Nasdaq GlobeNewswire

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

18 5 2023 08:19:00 提供 Nasdaq GlobeNewswire

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

17 4 2023 07:47:00 提供 Nasdaq GlobeNewswire

Biomerica Reports Q3 Fiscal 2023 Results

14 4 2023 16:48:29 提供 Nasdaq GlobeNewswire

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

08 3 2023 08:19:00 提供 Nasdaq GlobeNewswire

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

07 3 2023 16:39:57 提供 Nasdaq GlobeNewswire

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

03 3 2023 07:30:00 提供 Nasdaq GlobeNewswire

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

02 3 2023 17:15:01 提供 Nasdaq GlobeNewswire

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

13 1 2023 18:39:00 提供 Nasdaq GlobeNewswire

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board

10 1 2023 08:19:00 提供 Nasdaq GlobeNewswire

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

08 12 2022 08:19:00 提供 Nasdaq GlobeNewswire

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

02 11 2022 08:19:00 提供 Nasdaq GlobeNewswire